ALTERNATE DAY LEVODOPA THERAPY IN PARKINSONISM

[1] HYPERACTIVITY OF REMAINING DOPAMINERGIC NEURONS AFTER PARTIAL DESTRUCTION OF NIGRO-STRIATAL DOPAMINERGIC SYSTEM IN RAT [J]. NATURE-NEW BIOLOGY, 1973, 245 (144): : 150 - 151

[2] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[3] CONSIDERATIONS IN MANAGEMENT OF PARKINSONISM [J]. NEUROLOGY, 1978, 28 (01) : 5 - 7

[4] GOLDSTEIN M., 1967, BRAIN RES, V4, P298, DOI 10.1016/0006-8993(67)90013-3

[5] MECHANISMS OF ACTION OF L-DOPA IN PARKINSONS-DISEASE [J]. LIFE SCIENCES, 1974, 15 (07) : 1249 - 1259

[6] HORNYKIEWICZ O, 1979, ADV NEUROL, V24, P275

[7] ATTEMPTED USE OF HALOPERIDOL IN TREATMENT OF L-DOPA INDUCED DYSKINESIAS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1974, 37 (04) : 427 - 430

[8] KOLLER WC, 1981, NEUROLOGY, V31, P473

[9] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J]. NATURE, 1978, 273 (5657) : 59 - 61

[10] LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453

[1] HYPERACTIVITY OF REMAINING DOPAMINERGIC NEURONS AFTER PARTIAL DESTRUCTION OF NIGRO-STRIATAL DOPAMINERGIC SYSTEM IN RAT [J]. NATURE-NEW BIOLOGY, 1973, 245 (144): : 150 - 151

[2] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5

[3] CONSIDERATIONS IN MANAGEMENT OF PARKINSONISM [J]. NEUROLOGY, 1978, 28 (01) : 5 - 7

[4] GOLDSTEIN M., 1967, BRAIN RES, V4, P298, DOI 10.1016/0006-8993(67)90013-3

[5] MECHANISMS OF ACTION OF L-DOPA IN PARKINSONS-DISEASE [J]. LIFE SCIENCES, 1974, 15 (07) : 1249 - 1259

[6] HORNYKIEWICZ O, 1979, ADV NEUROL, V24, P275

[7] ATTEMPTED USE OF HALOPERIDOL IN TREATMENT OF L-DOPA INDUCED DYSKINESIAS [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1974, 37 (04) : 427 - 430

[8] KOLLER WC, 1981, NEUROLOGY, V31, P473

[9] RECEPTOR BASIS FOR DOPAMINERGIC SUPER-SENSITIVITY IN PARKINSONS-DISEASE [J]. NATURE, 1978, 273 (5657) : 59 - 61

[10] LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453